LeslieRLaufmanMD

Hematology • Columbus, OH

Myeloproliferative Disorder Hematology-Oncology

Physician

Join to view full profile

Dr. Laufman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Laufman's full profile

Already have an account?

Office
2975 Donnylane Blvd
Columbus, OH 43235
Phone+1 614-366-8380

Fax+1 614-366-8557
Is this information wrong?

Education & Training

Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1975 - 1976
Ohio State University HospitalResidency, Internal Medicine, 1974 - 1975
UPMC Medical EducationResidency, Internal Medicine, 1972 - 1974
University of Pittsburgh School of MedicineClass of 1972

Certifications & Licensure

OH State Medical License 1976 - 2016

Clinical Trials

A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer Start of enrollment: 2003 Oct 01
Unknown status
Phase 2
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Completed

Publications & Presentations

PubMed

353 citations
Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer With...
Joaquim Bellmunt, Hans von der Maase, Graham M. Mead, Iwona Skoneczna, Maria De Santis, Gedske Daugaard, Andreas Boehle, Christine Chevreau, Luis Paz-Ares, Leslie R. L...> ;Journal of Clinical Oncology. 2012 Apr 1
1 citations
Primary androgen deprivation therapy in men with prostate cancer.
Leslie Laufman> ;JAMA. 2009 Jan 7
A phase II study of oral MKC-1 for metastatic breast cancer (MBC).
Schneider BP, Karwal M, Laufman L, Sylvester L, Taylor MA, Sidor C, Hannah A, Arnott J, Miller KD> ;J. Clin. Oncol.. 2008-05-20
189 citations
Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy
David H. Henry, Naomi V. Dahl, Michael Auerbach, Simon Tchekmedyian, Leslie R. Laufman> ;The Oncologist. 2007 Feb 1
Gemcitabine and docetaxel for metastatic breast cancer-Further data.
Laufman LR, Spiridonidis CH, Parker T, Boury P, Maggard V, Miller S> ;J. Clin. Oncol.. 2006-06-20
4 citations
Phase I Study of Doxil® and Vinorelbine in Patients with Advanced Malignancies
Leslie R. Laufman, C. Harris Spiridonidis, Jacqueline J. Jones, Virginia Rhodes, Karen Rossi, Kelly Wallace> ;Cancer Investigation. 2004 Aug 18
Smoking status affects chemotherapy-induced neutropenia.
Laufman LR, Spiridonidis H, Laufman H, Baker L, Kuebler P, Young D> ;J. Clin. Oncol.. 2004-07-15
Symptomatic response to a non-platinum doublet in performance status 2 (PS 2) patients (pts) with non-small lung cancer (NSCLC).
Spiridonidis H, Tao M, Laufman L, Laufman H, Weiss M, Ganz P> ;J. Clin. Oncol.. 2004-07-15
98 citations
Multicenter Phase II Study of Oral Bexarotene for Patients With Metastatic Breast Cancer
Francisco J. Esteva, John A. Glaspy, Said Baidas, Leslie R. Laufman, Laura F. Hutchins, Maura N. Dickler, Debasish Tripathy, Roger B. Cohen, Angela DeMichele, Richard ...> ;Journal of Clinical Oncology. 2003 Mar 15
Overlooking patient outcomes in a meta-analysis of trials of granulocyte colony-stimulating factor.
Leslie R. Laufman, C. Harris Spiridonidis> ;The American Journal of Medicine. 2002 Dec 15
45 citations
Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial
L. R. Laufman, C. H. Spiridonidis, J. Pritchard, R. Roach, J. Zangmeister, N. Larrimer, T. Moore, M. Segal, J. Jones, T. Patel, L. Gutterman, L. Carman, D. Colborn, J....> ;Annals of Oncology. 2001 Sep 1
143 citations
Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study
Martin Schuler, R. Herrmann, J. L.P. De Greve, A. K. Stewart, U. Gatzemeier, D. J. Stewart, L. Laufman, R. Gralla, Jürgen Kuball, Roland Buhl, Claus P. Heussel, Friedr...> ;Journal of Clinical Oncology. 2001 Mar 15
42 citations
Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial
C. H. Spiridonidis, L. R. Laufman, L. Carman, Timothy Moore, S. Blair, J. Jones, Ch. George, T. Patel, R. Roach, R. Rupert, J. Zangmeister, D. Colborn, J.Ph. Kuebler> ;Annals of Oncology. 2001 Jan 1
4 citations
Docetaxel and gemcitabine combinations in chemotherapy-pretreated non small-cell lung cancer.
C. Harris Spiridonidis, Leslie R. Laufman> ;Clinical Lung Cancer. 2000 Apr 1
182 citations
Further Evaluation of Intensified and Increased Total Dose of Cyclophosphamide for the Treatment of Primary Breast Cancer: Findings From National Surgical Adjuvant Bre...
Bernard Fisher, Stewart J. Anderson, Arthur DeCillis, Nikolay V. Dimitrov, James N. Atkins, Louis Fehrenbacher, Patrick H. Henry, Edward H. Romond, Keith S. Lanier, En...> ;Journal of Clinical Oncology. 1999 Nov 1
4 citations
Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung cancer: A phase II trial of a novel schedule
C. H. Spiridonidis, L. R. Laufman, J. Jones, V. A. Rhodes> ;Annals of Oncology. 1999 Aug 1
62 citations
Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies.
C. H. Spiridonidis, L. R. Laufman, J. Jones, V. A. Rhodes, K Wallace, S Nicol> ;Journal of Clinical Oncology. 1998 Dec 1
10 citations
CONCURRENT CISPLATIN, PROLONGED ORAL ETOPOSIDE, AND VINCRISTINE PLUS CHEST AND BRAIN IRRADIATION FOR LIMITED SMALL CELL LUNG CANCER: A PHASE II STUDY OF THE SOUTHWEST ...
Charles R. Thomas, Dori J Giroux, Keith J. Stelzer, Johnny B Craig, Leslie Rodgers Laufman, Sarah A Taylor, John W Goodwin, John Crowley, Robert Livingston> ;International Journal of Radiation Oncology, Biology, Physics. 1998 Mar 15
39 citations
Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study.
Eric H. Kraut, J. J. Crowley, James L. Wade, Leslie R. Laufman, Melissa Alsina, Sarah A. Taylor, Sydney E. Salmon> ;Journal of Clinical Oncology. 1998 Feb 1
8 citations
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
P. N. Grozea, John Crowley, Vikki A. Canfield, Laura Kingsbury, S. William Ross, German Beltran, Leslie R. Laufman, Geoffrey R. Weiss, Robert B. Livingston> ;Cancer. 1997 Sep 15
23 citations
A Phase II Evaluation of High Dose Cisplatin and Etoposide in Patients with Advanced Esophageal Adenocarcinoma
C. Harris Spiridonidis, Leslie R. Laufman, Jacqueline J. Jones, D. Jeffrey Gray, Chuck C. Cho, Donn C. Young> ;Cancer. 1996 Nov 15
70 citations
Photodynamic therapy for esophageal malignancy: A prospective twelve-year study
James S. McCaughan, E. Christopher Ellison, Jerry T. Guy, William J. Hicks, Jacqueline J. Jones, Leslie R. Laufman, Eugene May, Thomas A. Nims, C. Harris Spiridonidis,...> ;The Annals of Thoracic Surgery. 1996 Oct 1
1 citations
High-dose chemotherapy for breast cancer.
C H Spiridonidis, L R Laufman, V Rhodes, J Jones> ;Journal of Clinical Oncology. 1996 Feb 1
154 citations
Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.
Stephen E. Jones, Eric P. Winer, Charles L. Vogel, Leslie R. Laufman, Laura F. Hutchins, Mark Allen O'Rourke, Barry C. Lembersky, Daniel R. Budman, Joseph Bigley, John...> ;Journal of Clinical Oncology. 1995 Oct 1
18 citations
Quality of life in patients with metastatic colorectal cancer receiving chemotherapy : a randomized, double blind trial comparing 5-FU versus 5-FU with leucovorin
Beverly A. Sullivan, Ray McKinnis, Leslie R. Laufman> ;Pharmacotherapy. 1995 Sep 10
Join now to see all

Grant Support

Cancer Information ExchanceNational Cancer Institute1998
Cancer Information Exchange (CIX)National Cancer Institute1997
Columbus Community Clinical Oncology ProgramNational Cancer Institute1995–1996
Columbus Community Clincal Oncology ProgramNational Cancer Institute1991–1994

Hospital Affiliations

OhioHealth Grady Memorial HospitalDelaware, Ohio
OhioHealth Riverside Methodist HospitalColumbus, Ohio